ROIV:NASDAQ
Roivant Sciences Ltd
$38.22
arrow_downward
-1.97%(-0.77) 1D
$38.37
arrow_upward
+0.39% (+0.15)bedtimeAfter hours
Closed: Sep 22, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$38.73
High
$39.17
Low
$38.11
Mkt. cap
27.61B
Avg. vol.
8.91M
Volume
0.00
52-wk high
$42.50
52-wk low
$14.50
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
Open
$38.73
High
$39.17
Low
$38.11
Mkt. cap
27.61B
Avg. vol.
8.91M
Volume
0.00
52-wk high
$42.50
52-wk low
$14.50
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
Stock Titan
·
6 hours ago
Roivant (ROIV) CAO uses 3,880 shares to cover RSU taxes
Investing.com Canada
·
6 hours ago
Form 4 Roivant Sciences Ltd. For: 22 September By Investing.com
Investing.com India
·
6 hours ago
Form 4 Roivant Sciences Ltd. For: 22 September
Stock Titan
·
8 hours ago
Roivant Sciences (ROIV) CFO now holds 269,681 shares after RSU tax withholding
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd